Upjohn To Divest Three In Australia To Complete On Viatris
ACCC Nod Moves $12bn Merger With Mylan Closer To Completion
Another regulatory approval for Mylan and Upjohn’s proposed combination into Viatris has been ticked off, with the Australian Competition and Consumer Commission saying it will not oppose the deal after Upjohn agreed to divestments to Aspen Pharmacare.
